Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Understanding Fatigue in Primary Biliary Cholangitis

Lookup NU author(s): Dr April Phaw, Dr Jess Dyson, Professor David Jones

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

© 2020, Springer Science+Business Media, LLC, part of Springer Nature. Background: Fatigue affects 50% of primary biliary cholangitis patients and is severe in approximately 20%, significantly affecting quality of life. The pathogenesis of fatigue in primary biliary cholangitis is poorly understood. This study aimed to explore subgroups of fatigue to support targeting of selected groups in future clinical trials. Methods: Data were derived from the UK-PBC cohort. Participants completed the PBC-40, Hospital Anxiety and Depression Score, Epworth Sleepiness Scale, and Orthostatic Grading Scale for symptoms assessment. Fatigue and cognitive symptoms were regarded as clinically significant if they exceeded the previously defined cutoff for “moderate” symptom. Results: Of 2002, patients for whom full PBC-40, fatigue, and cognitive symptom domain scores were available, 1203 (60%) had significant fatigue and 730 (36%) had significant cognitive symptoms. Among the 1203 patients with significant fatigue, 663 (55%) also had significant cognitive symptoms (termed fatigue with cognitive symptoms) with a significant linear association between the fatigue and cognitive symptom severity. “Fatigue with cognitive symptoms” patients were younger and more likely to have severe fatigue. They also experienced greater social and emotional impact. Conclusions: Fatigue in PBC is complex, and there has been no progress to date in identifying therapies able to improve it. One factor in slow progress may be the heterogeneity of patients describing fatigue complicating effective cohort selection for clinical trials. This study has identified potential discrete subgroups of fatigued patients with and without cognitive symptoms. The group of patients expressing “fatigue with cognitive symptoms” was homogenous and may represent a coherent cohort for clinical trials.


Publication metadata

Author(s): Phaw NA, Dyson JK, Mells G, Jones D

Publication type: Article

Publication status: Published

Journal: Digestive Diseases and Sciences

Year: 2021

Volume: 66

Pages: 2380-2386

Print publication date: 01/07/2021

Online publication date: 26/08/2020

Acceptance date: 18/07/2020

ISSN (print): 0163-2116

ISSN (electronic): 1573-2568

Publisher: Springer

URL: https://doi.org/10.1007/s10620-020-06502-0

DOI: 10.1007/s10620-020-06502-0


Altmetrics

Altmetrics provided by Altmetric


Share